1. Intranasal nanocarrier-based drug delivery in multiple sclerosis: therapeutic cargo, CNS targeting and translational challenges
Parseghian L, Sanadgol N, Negah Ss, Fahanik-Babaei J, Rafati H
Efficiently delivering therapeutics to the central nervous system (CNS) remains a major challenge in multiple sclerosis (MS), particularly for strategies targeting CNS-resident pathology, neuroprotection, or remyelination. This review provides a delivery- and formulation-centered comparative analysis of CNS drug…
- Blood–brain barrier
- CNS targeting
- Intranasal delivery
- Multiple sclerosis
- Nanocarriers
- Nanomedicine
- Nanotechnology
- Nose-to-brain transport
- Surface-functionalized nanoparticles
